110 Organometallics, Vol. 21, No. 1, 2002
Nachtigal et al.
Com p lex 3c. Complex 2 (300 mg, 0.454 mmol) was treated
with c (0.043 mL, 0.50 mmol) to give 3c: yield 304 mg (91%)
of a yellow powder. 1H NMR (CDCl3): δ 0.9 (d, 3J HH ) 4.5 Hz,
3H, CHCH3), 1.9-2.2 (m, 1H, CHCH3), 2.4-3.3 (m, 14H, PCH2,
CH2O, NH2, NH2CH2), 2.9 (br, 6H, OCH3), 7.2-7.8 (m, 20H,
was added to a solution of the neutral complexes 3a -g in 25
mL of dichloromethane and stirred for 24 h. After filtration
through silica the solution was concentrated to about 5 mL
under reduced pressure. The corresponding cationic complex
was precipitated by addition of 100 mL of diethyl ether, filtered
off (P3), washed three times with 25 mL portions of diethyl
ether, and dried under vacuum.
Use of AgBF 4. A solution of AgBF4 (5% excess) in 25 mL of
dichloromethane was added to a solution of the neutral
complexes 3a -g in 25 mL of dichloromethane and stirred for
4 h. After filtration through silica the solution was concen-
trated to a small volume. Adding 100 mL of diethyl ether
caused the precipitation of a solid, which was filtered off (P3),
washed three times with 25 mL portions of diethyl ether, and
dried under vacuum.
2
C6H5). 31P{1H} NMR (CDCl3): δ 39.1, 38.9 (AB pattern, J PP
) 36.7 Hz). 13C{1H} NMR (CDCl3): δ 20.4 (s, CCH3), 25.4 (m,
PCH2), 49.6 (s, NCH), 50.9 (s, NCH2), 58.0 (s, OCH3), 69.1 (d,
3
2J PC ) 4.0 Hz, CH2O), 128.1 (d, J PC ) 4.9 Hz, m-C6H5), 128.2
3
(d, J PC ) 6.4 Hz, m-C6H5), 129.0, 129.3 (2s, p-C6H5), 132.3,
2
133.2 (2d, J PC ) 6.4 Hz, o-C6H5), 134.8-133.8 (m, i-C6H5).
FD-MS: m/z 734.6 (M+). Anal. Calcd for C33H44Cl2N2O2P2Ru:
C, 53.95; H, 6.04; N, 3.81; Cl, 9.65. Found: C, 53.53; H, 5.75;
N, 3.75; Cl, 9.38.
Com p lex 3d . Complex 2 (300 mg, 0.454 mmol) was treated
with d (54 mg, 0.50 mmol) to give 3d : yield 206 mg (59%) of
a pale yellow powder. 1H NMR (CDCl3): δ 2.2-2.4 (m, 4H,
PCH2), 2.9 (m, 6H, OCH3), 2.9-3.0 (m, 4H, CH2O), 4.5 (s, 4H,
NH2), 6.8-7.0 (m, 4H, C6H4), 7.1-7.7 (m, 20H, C6H5). 31P{1H}
NMR (CDCl3): δ 40.7 (s). 13C{1H} NMR (CDCl3): δ 25.2 (m,45a
N ) 26.5 Hz, PCH2), 58.0 (s, OCH3), 69.1 (m,45b N ) 5.0 Hz,
CH2O), 127.3 (s, C3, C6), 127.8 (s, C4, C5), 128.4 (m,45b N )
8.5 Hz, m-C6H5), 129.4 (s, p-C6H5), 132.8 (m,45c N ) 8.4 Hz,
o-C6H5), 134.2 (m,45a N ) 36.3 Hz, i-C6H5), 140.1 (s, C1, C2).
31P{1H} NMR (CDCl3) for the C1 isomer: δ 37.6 (d, 2J PP ) 34.9
Com p lex 4a . Complex 3a (300 mg, 0.416 mmol) was treated
with TlPF6 (153 mg, 0.437 mmol) to give 4a : yield 252 mg
(73%) of a yellow powder. 1H NMR (CD2Cl2): δ 0.9-1.5 (m,
2H, CH2P), 2.1-2.8 (m, 10H, CH2NH2, CH2P), 2.9 (s, 3H,
OCH3), 2.9-3.1 (m, 2H, CH2O), 3.6 (s, 3H, OCH3), 3.7-4.0 (m,
2H CH2O), 6.5-8.1 (m, 20H, C6H5). 31P{1H} NMR (CD2Cl2): δ
57.5 (d, 2J PP ) 37.8 Hz), 48.5 (d, 2J PP ) 37.8 Hz), -143.3 (sept,
1J PF ) 712.1 Hz, PF6-). 13C{1H} NMR (CD2Cl2): δ 28.6 (d, 1J PC
1
) 28.5 Hz, PCH2), 32.2 (d, J PC ) 25.6 Hz, PCH2), 43.7, 45.5
(2s, NCH2), 58.5, 61.3 (2s, OCH3), 68.6, 73.9 (2s, CH2O), 128.6
2
Hz), 47.5 (d, J PP ) 34.9 Hz). FD-MS: m/z 768.7 (M+), 660.5
(d, 3J PC ) 10.0 Hz, m-C6H5), 129.1(d, 3J PC ) 10.0 Hz, m-C6H5),
(M+ - C6H8N2). Anal. Calcd for C36H42Cl2N2O2P2Ru: C, 56.25;
H, 5.51; N, 3.64; Cl, 9.22. Found:46 C, 55.64; H, 5.97; N, 3.82;
Cl, 8.94.
3
3
129.9 (d, J PC ) 10.0 Hz, m-C6H5), 130.0 (d, J PC ) 10.0 Hz,
2
m-C6H5), 130.8-130.9 (br, p-C6H5), 131.6 (d, J PC ) 9.0 Hz,
2
2
o-C6H5), 131.9 (d, J PC ) 9.0 Hz, o-C6H5), 133.0 (d, J PC
)
1
Com p lex 3e. Compound 2 (300 mg, 0.454 mmol) was
treated with e (79 mg, 0.50 mmol) to give 3e: yield 299 mg
(84%) of a tawny powder. 1H NMR (CDCl3): δ 2.3-2.4 (m, 4H,
PCH2), 2.9 (s, 6H, OCH3), 2.9-3.1 (m, 4H, CH2O), 5.1 (s, 4H,
NH2), 6.4-7.5 (m, 6 H, C10H6), 7.3-7.7 (m, 20H, C6H5).
31P{1H} NMR (CD2Cl2): δ 43.9 (s). 13C{1H} NMR (CD2Cl2): δ
25.7 (m,45a N ) 26.3 Hz, PCH2), 58.2 (s, OCH3), 69.5 (s, CH2O),
121.7 (s, C2, C7), 125.2 (s, C8a), 126.0 (s, C4, C5), 126.9 (s,
C3, C6), 128.8 (m,45b N ) 8.5 Hz, m-C6H5), 129.8 (s, p-C6H5),
9.0 Hz, o-C6H5), 134.1 (d, J PC ) 44.1 Hz, i-C6H5), 135.1 (d,
2J PC ) 10.0 Hz, o-C6H5), 138,1 (d, J PC ) 37.7 Hz, i-C6H5).
1
FD-MS: m/z 685.2 (M+ - PF6). Anal. Calcd for C32H42
-
ClF6N2O2P3Ru: C, 46.30; H, 5.10; N, 3.37. Found: C, 45.92;
H, 5.37; N, 3.39.
Com p lex 4b. Complex 3b (300 mg, 0.408 mmol) was treated
with TlPF6 (150 mg, 0.429 mmol) to give 4b: yield 238 mg
(69%) of a yellow powder. 1H NMR (CD2Cl2): δ 0.6-4.2 (br m,
16H, CH2P, H2NCH2CH2CH2NH2, CH2O), 2.9, 3.8 (2s, 6H,
OCH3), 6.3-8.2 (m, 20H, C6H5). 31P{1H} NMR (CD2Cl2): isomer
133.7 (m,45c N ) 7.8 Hz, o-C6H5), 134.2 (s, C4a), 136.1 (m,45a
N
) 44.8 Hz, i-C6H5), 136.8 (s, C1, C8). FD-MS: m/z 783.3 (M+
- Cl), 660.5 (M+ - C10H10N2). Anal. Calcd for C40H44Cl2N2O2P2-
Ru: C, 58.68; H, 5.42; N, 3.42; Cl, 8.66. Found:46 C, 57.89; H,
5.43; N, 3.52; Cl, 9.03.
2
2
a (94%), δ 54.3 (d, J PP ) 36.5 Hz), 47.8 (d, J PP ) 36.5 Hz),
-143.3 (sept, 1J PF ) 711.8 Hz, PF6-); isomer b (6%), δ 63.4 (d,
2J PP ) 32.4 Hz), 32.4 (d, J PP ) 32.4 Hz), -143.3 (sept, J PF
)
2
1
711.8 Hz, PF6-). 13C{1H} NMR (CD2Cl2): isomer a, δ 27.5 (d,
1J PC ) 27.5 Hz, PCH2), 28.8 (s, NCH2CH2), 30.8 (d, 1J PC ) 26.0
Hz, PCH2), 41.4, 43.1 (2s, NCH2), 58.3, 61.7 (2s, OCH3), 68.2,
Com p lex 3f. Complex 2 (300 mg, 0.454 mmol) was treated
with f (78 mg, 0.50 mmol) to give 3f: yield 323 mg (87%) of a
1
3
auburn powder. H NMR (CDCl3): δ 2.5-2.6 (m, 4H, PCH2),
74.0 (2s, CH2O), 128.7 (d, J PC ) 9.2 Hz, m-C6H5), 129.2 (d,
2.8 (s, OCH3), 2.8-3.0 (m, 4H, CH2O), 6.6-8.7 (m, 28H, C10H8,
C6H5). 31P{1H} NMR (CDCl3): δ 30.5 (s). 13C{1H} NMR
(CDCl3): δ 26.8 (m,45a N ) 29.1 Hz, PCH2), 57.8 (s, OCH3),
69.4 (s, CH2O), 122.2 (s, C4, C4′), 123.9 (s, C6, C6′), 128.0 (m,45b
N ) 8.5 Hz, m-C6H5), 129.3 (s, p-C6H5), 133.3-134.1 (m, i-C6H5,
o-C6H5), 136.0 (s, C5, C5′), 156.6 (s, C3, C3′), 158.7 (s, C1, C1′).
31P{1H} NMR (CDCl3) for the C1 isomer: δ 29.3 (d, 2J PP ) 30.2
3J PC ) 9.0 Hz, m-C6H5), 130.1 (br, m-C6H5), 131.0 (br, p-C6H5),
2
131.2 (br, p-C6H5), 132.0 (d, J PC ) 8.0 Hz, o-C6H5), 132.4 (d,
2J PC ) 8.0 Hz, o-C6H5), 133.3 (d, J PC ) 9.0 Hz, o-C6H5), 134.9
2
2
1
(d, J PC ) 9.0 Hz, o-C6H5), 136.2 (d, J PC ) 41.0 Hz, i-C6H5).
FD-MS: m/z 699.2 (M+ - PF6). Anal. Calcd for C33H44
-
ClF6N2O2P3Ru: C, 46.95; H, 5.25; N, 3.32. Found: C, 47.27;
H, 4.95; N, 3.31.
2
Hz), 33.4 (d, J PP ) 30.2 Hz). FD-MS: m/z 816.7 (M+). Anal.
Com p lex 4c. Compound 3c (300 mg, 0.408 mmol) was
treated with AgBF4 (83 mg, 0.429 mmol) to give 4c: yield 218
mg (68%) of a yellow powder. 1H NMR (CD2Cl2): δ 0.4-4.3
(m, 33H, CH2P, H2NCH2CHNH2, CH2O), 0.8 (d, 2J HH ) 6.3 Hz,
Calcd for C40H42Cl2N2O2P2Ru: C, 58.83; H, 5.18; N, 3.43; Cl,
8.68. Found:46 C, 58.14; H, 5.32; N, 3.52; Cl, 8.69.
Com p lex 3g. Compound 2 (300 mg, 0.454 mmol) was
treated with g (90 mg, 0.50 mmol) to give 3g: yield 351 mg
2
3H, CHCH3), 1.1 (d, J HH ) 6.6 Hz, 6H, CHCH3), 3.0 (s, 3H,
1
(92%) of a deep red powder. H NMR (CDCl3): δ 2.5-2.7 (m,
OCH3), 3.1 (s, 6H, OCH3), 3.6 (s, 3H, OCH3), 3.7 (s, 6H, OCH3),
4H, PCH2), 2.8 (s, OCH3), 2.8-3.0 (m, CH2O), 7.0-9.0 (m, 28H,
C6H5, C12H8). 31P{1H} NMR (CDCl3): δ 30.5 (s). 13C{1H} NMR
(CDCl3): δ 26.7 (m,45a N ) 29.2 Hz, PCH2), 57.6 (s, OCH3),
69.2 (s, CH2O), 123.1 (s, C3, C8), 126.8 (s, C5, C6), 127.8 (m,45b
N ) 8.5 Hz, m-C6H5), 129.1 (s, p-C6H5), 130.0 (s, C4a, C6a),
133.4 (m,45a N ) 34.2 Hz, i-C6H5), 134.1 (br m,45c o-C6H5), 135.1
(s, C4, C7), 149.2 (s, C10a, C10b), 156.0 (s, C2, C9). FD-MS:
m/z 840.7 (M+). Anal. Calcd for C42H42Cl2N2O2P2Ru: C, 60.00;
H, 5.03; N, 3.33; Cl, 8.43. Found:46 C, 59.36; H, 5.34; N, 3.64,
Cl, 8.69.
6.2-8.3 (m, 20H, C6H5). 31P{1H} NMR (CD2Cl2): isomer a
2
2
(55%), δ 59.1 (d, J PP ) 37.2 Hz), 48.2 (d, J PP ) 37.2 Hz);
2
2
isomer b (25%), δ 57.6 (d, J PP ) 37.2 Hz), 47.8 (d, J PP ) 37.2
2
2
Hz); isomer c (20%), δ 56.8 (d, J PP ) 36.3 Hz), 49.9 (d, J PP
)
36.3 Hz). 13C{1H} NMR (CD2Cl2): δ 18.2, 18.6, 20.0 (3s,
CHCH3), 30.0-32.6 (m, PCH2), 51.2 (br, NCH2), 52.2 (br,
NCH), 58.7, 60.7, 61.0 (3s, OCH3), 68.8, 68.9, 73.8 (3s, CH2O),
128.4-137.0 (C6H5). FD-MS: m/z 699.2 (M+ - BF4). Anal.
Calcd for C33H44BClF4N2O2P2Ru: C, 50.43; H, 5.64; N, 3.56.
Found: C, 49.97; H, 5.73; N, 3.32.
Gen er a l P r oced u r e for th e P r ep a r a tion of th e Mon o-
ca tion ic Com p lexes 4a -c,f. Use of TlP F 6. TlPF6 (5% excess)
Com p lex 4d . Compound 3d (300 mg, 0.390 mmol) was
treated with AgBF4 (79 mg, 0.410 mmol) to give 4d : yield 337